Creatinine and urea levels (Median: 63.13 and 2.6) were significantly (P < 0.001) lower and albumin (Median: 37.1) significantly (P = 0.096) lower in the test participants, relative to control group participants at the end of 2 months of TB treatment (Table 4). The gene discussed is ALB; the disease is tuberculosis.